First Header Logo Second Header Logo

Connection

Travis Dotson to Protein Kinase Inhibitors

Back to Details
This is a "connection" page, showing publications Travis Dotson has written about Protein Kinase Inhibitors.
Travis Dotson
Connection Strength
0.027
Protein Kinase Inhibitors
  1. Petty WJ, Laudadio J, Brautnick L, Lovato J, Dotson T, Streer NP, Weaver KE, Miller AA. Phase II trial of dose-dense chemotherapy followed by dose-intense erlotinib for patients with newly diagnosed metastatic non-small cell lung cancer. Int J Oncol. 2013 Dec; 43(6):2057-63.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.